Which one, gastric parietal cell antibody positivity or hyperhomocysteinemia, is a better biomarker to predict oral mucosal disease patients with vitamin B12 deficiency?

Which one, gastric parietal cell antibody positivity or hyperhomocysteinemia, is a better biomarker to predict oral mucosal disease patients with vitamin B12 deficiency? J Formos Med Assoc. 2020 Aug 24;: Authors: Sun A, Chang JY, Chiang CP PMID: 32855035 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32855035?dopt=Abstract

Source: J Formos Med Assoc - August 23, 2020 Category: General Medicine Authors: Sun A, Chang JY, Chiang CP Tags: J Formos Med Assoc Source Type: research

More News: Gastroenterology | General Medicine | Vitamin B12 | Vitamin B12 Deficiency | Vitamins